Sarah Boyce Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sarah Boyce.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sarah Boyce. Sarah Boyce is a Director in LIGAND PHARMACEUTICALS INC ($LGND) and a Chief Business Officer in IONIS PHARMACEUTICALS INC ($ISIS) and a President and CEO in Avidity Biosciences, Inc. ($RNA) and a President in AKCEA THERAPEUTICS, INC. ($AKCA) and a Director in Berkeley Lights, Inc. ($BLI).
Address: C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD 92010 CA
Companies in which Sarah Boyce is an Insider
AKCEA THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah Boyce: President
Holdings: 19,888 shares
Latest Transaction: Jul 17 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Avidity Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah Boyce: President and CEO
Holdings: 0 shares
Latest Transaction: Feb 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Berkeley Lights, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Sarah Boyce: Director
Holdings: 1,400 shares
Latest Transaction: May 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IONIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah Boyce: Chief Business Officer
Holdings: 11,127 shares
Latest Transaction: Jan 17 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LIGAND PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah Boyce: Director
Holdings: 2,892 shares
Current Value: $311,873
Latest Transaction: Jun 07 2021
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sarah Boyce
Sentiment: All, AKCA, RNA, BLI, ISIS, LGND
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 630 | 0 | 2,892 | 2.3 K to 2.9 K (+27.85 %) |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 630 | 0 | 2,892 | 2.3 K to 2.9 K (+27.85 %) |
| May 18 2021 | BLI | Berkeley Lights, I ... | Boyce Sarah | Director | Option Exercise | A | 37.13 | 4,900 | 181,937 | 4,900 | |
| May 18 2021 | BLI | Berkeley Lights, I ... | Boyce Sarah | Director | Grant | A | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
| Mar 03 2021 | BLI | Berkeley Lights, I ... | Boyce Sarah | Director | Option Exercise | M | 8.90 | 10,000 | 89,000 | 90,000 |